LSE:DPH (Dechra Pharmaceuticals PLC)

About DPH

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. It listed in London in 2000.
  • Dechra Pharmaceuticals PLC (LSE: DPH) Latest News

    Investing Articles

    This FTSE 250 dog might be a stonking contrarian pick

    Today's trading update suggests investors are being far too negative on this FTSE 250 (INDEXFTSE:MCX) stock.

    Read more »

    Investing Articles

    2 surprising growth stocks that could help you retire early

    These two shares may offer higher growth rates than expected.

    Read more »

    Investing Articles

    These great growth stocks have much further to go

    Royston Wild looks at two stocks with hot earnings prospects.

    Read more »

    Investing Articles

    One growth stock I’d buy — and one I’d sell — right now

    Royston Wild discusses two growth stocks with very different near-term outlooks.

    Read more »

    Investing Articles

    Enjoy double-digit earnings growth with these FTSE 250 stars

    Royston Wild looks at three FTSE 250 (INDEXFTSE: MCX) stocks with spectacular earnings potential.

    Read more »

    Investing Articles

    Why I’m avoiding these exciting growth shares right now

    Bilaal Mohamed explains why investors should wait before buying these growth stocks.

    Read more »

    Investing Articles

    Should you make room for Pets At Home Group plc after today’s update?

    The market may not like today's update but Paul Summers thinks Pets At Home Group plc (LON:PETS) is a sound…

    Read more »

    Investing Articles

    Does this pharma’s 56% sales growth make it a better buy than GlaxoSmithKline plc?

    Should you sell GlaxoSmithKline plc (LON: GSK) and pile into this hot pharma stock?

    Read more »

    Investing Articles

    4 growth stocks to put on your 2017 shopping list

    Royston Wild runs the rule over some of London’s hottest growth stocks.

    Read more »

    Investing Articles

    Could these top-performing stocks be about to collapse?

    Bilaal Mohamed considers whether these shares are heading for a correction after this year's spectacular gains.

    Read more »

    Investing Articles

    2 shining pharmaceuticals stars to challenge the big guns?

    Can these smaller upstarts beat the champions at their own game?

    Read more »

    Investing Articles

    Is Dechra Pharmaceuticals plc a better buy than GlaxoSmithKline plc after today’s news?

    Royston Wild weighs up the investment potential of drugs deities Dechra Pharmaceuticals plc (LON: DPH) and GlaxoSmithKline plc (LON: GSK).

    Read more »